Efficacy and parameter-kinetics of mac-2 binding protein glycosylation isomer (M2BPGi) and magnetic resonance elastography in hepatitis C patients treated with direct-acting antiviral therapy：A case series of 5 hemodialysis patients-Reference-Cited by-同舟云学术

Efficacy and parameter-kinetics of mac-2 binding protein glycosylation isomer (M2BPGi) and magnetic resonance elastography in hepatitis C patients treated with direct-acting antiviral therapy：A case series of 5 hemodialysis patients

Published:2022 Issue:11 Volume:55 Page:645-652
ISSN:1340-3451
Container-title:Nihon Toseki Igakkai Zasshi
language:en
Short-container-title:Nihon Toseki Igakkai Zasshi

Author:

Nishizawa Yoko¹,Ohno Hideki²,Kimura Ayako²,Hirasawa Eriko¹,Tosaka Mai¹,Hosoda Yumi¹,Yamaguchi Erika¹,Horimoto Ai¹,Omae Kiyotsugu¹,Tsuchiya Ken³,Nitta Kosaku³,Sakura Hiroshi²,Ogawa Tetsuya¹

Affiliation:

1. Department of Medicine and Department of Blood Purification, Tokyo Womenʼs Medical University Adachi Medical Center

2. Department of Medicine, Tokyo Womenʼs Medical University Adachi Medical Center

3. Department of Nephrology, Tokyo Womenʼs Medical University

Publisher

Japanese Society for Dialysis Therapy

Subject

Organic Chemistry,Biochemistry

Link

https://www.jstage.jst.go.jp/article/jsdt/55/11/55_645/_pdf

Reference28 articles.

1. 1) 新田孝作，政金生人，花房規男，他．わが国の慢性透析療法の現況（2018年12月31日現在）．透析会誌 2019；52：679-754．

2. 2) Akuta N, Suzuki F, Sezaki H, et al. Complex Association of Virus- and Host-Related Factors with Hepatocellular Carcinoma Rate following Hepatitis C Virus Clearance. J Clin Microbiol 2019；57：e01463-18.

3. 3) Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases. Liver biopsy. Hepatology 2009；49：1017-44.

4. 4) Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 2007；47：598-607.

5. 5) Cui J, Heba E, Hernandez C, et al. Magnetic resonance elastography is superior to acoustic radiation force impulse for the Diagnosis of fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease：A prospective study. Hepatology 2016；63：453-61.